(NP (NP The/DT impaired/JJ transcription/NN factor/NN AP-1/NN DNA/NN binding/NN activity/NN) (PP in/IN (NP (NP lymphocytes/NNS) (VP derived/VBN (NP */-NONE-) (PP from/IN (NP (NP subjects/NNS) (PP with/IN (NP (NP some/DT symptoms/NNS) (PP of/IN (NP premature/JJ aging/NN))))))))) ./.)
(S (NP-SBJ (NP The/DT study/NN) (PP of/IN (NP (NP human/JJ disorders/NNS) (VP known/VBN (NP */-NONE-) (PP as/IN (NP premature/JJ aging/NN syndromes/NNS)))))) (VP may/MD (VP provide/VB (NP (NP insight/NN) (PP into/IN (NP (NP the/DT mechanisms/NNS) (PP of/IN (NP cellular/JJ senescence/NN))))))) ./.)
(S (NP-SBJ (NP The/DT main/JJ feature/NN) (PP of/IN (NP (NP cellular/JJ senescence/NN) (ADVP in/FW vitro/FW)))) (VP is/VBZ (NP-PRD (NP cessation/NN) (PP of/IN (NP cell/NN proliferation/NN)))) ./.)
(S (NP-SBJ-COOD-72 (NP (NP Down/NN syndrome/NN) (PRN -LRB-/-LRB- (NP DS/NN) -RRB-/-RRB-)) and/CC (NP (NP neuronal/JJ ceroid-lypofuscinosis/NN) (PRN -LRB-/-LRB- (NP NCL/NN) -RRB-/-RRB-))) (VP are/VBP (VP (ADVP clinically/RB) characterized/VBN (NP *-72/-NONE-) (PP by/IN (NP-LGS (NP the/DT premature/JJ onset/NN) (PP of/IN (NP (NP numerous/JJ features/NNS) (VP (ADVP normally/RB) associated/VBN (NP */-NONE-) (PP with/IN (NP human/JJ aging/NN))))))))) ./.)
(S (NP-SBJ (NP (ADJP (NP Phytohemagglutinin/NN) stimulated/JJ) lymphocytes/NNS) (VP derived/VBN (NP */-NONE-) (PP from/IN (NP DS/NN subjects/NNS)))) (VP showed/VBD (NP a/DT (ADJP statistically/RB significant/JJ) diminished/VBN proliferation/NN capacity/NN) (PP in/IN comparison/NN with/IN (NP (NP lymphocytes/NNS) (VP derived/VBN (NP */-NONE-) (PP from/IN (NP (UCP-COOD (NP NCL/NN) and/CC (ADJP healthy/JJ)) individuals/NNS)))))) ./.)
(S (NP-SBJ-73 We/PRP) (VP demonstrated/VBD ,/, (PP by/IN (S (NP-SBJ *-73/-NONE-) (VP applying/VBG (NP the/DT electrophoretic/JJ mobility/NN shift/NN assay/NN)))) ,/, (NP-COOD (NP (NP (ADJP-114 slightly/RB impaired/JJ) AP-1/NN DNA/NN binding/NN activity/NN) (PP-113 in/IN (NP NCL/NN lymphocytes/NNS))) and/CC (NP (ADJP=114 strong/JJ) (PP=113 in/IN (NP DS/NN ones/NNS))))) ./.)
(S (NP-SBJ Our/PRP$ results/NNS) (VP showed/VBD (SBAR that/IN (S (NP-SBJ (NP the/DT same/JJ molecular/JJ mechanisms/NNS) (PP of/IN (NP proliferation/NN cessation/NN))) (VP could/MD (VP exist/VB (PP-COOD (PP in/IN (NP (NP fibroblasts/NNS) (VP characterized/VBN (NP */-NONE-) (PP by/IN (NP-LGS replicative/JJ senescence/NN))))) and/CC (PP in/IN (NP (NP lymphocytes/NNS) (VP derived/VBN (NP */-NONE-) (PP from/IN (NP (NP individuals/NNS) (PP with/IN (NP (NP premature/JJ aging/NN syndromes/NNS) (PRN -LRB-/-LRB- (NP Down/NN) -RRB-/-RRB-)))))))))))))) ./.)
